It’s almost time to don your outfit for the 31st, but keep in mind some important safety tips, say doctors at Philadelphia’s Wills Eye Hospital, that may keep you from doing real harm to your eyes -potentially landing yourself in the emergency room and in some cases, risking permanent vision loss.
Wills Eye Hospital is listed Top in Ophthalmology Nationwide once again this year on the much sought-after U.S. News & World Report’s Best Hospitals 2015-2016 Rankings. The annual list recognizes hospitals that excel in treating the most challenging cases. The list is compiled from votes by thousands of doctors nationwide.
Patients, families, friends and physicians pay tribute to the many contributions that have been made during the past 40 years by the Wills Eye Ocular Oncology Service and Drs. Jerry and Carol Shields.
Nearly 3000 new eye cancer cases occur each year in adults and children.
The team at Wills Eye Hospital has the most advanced treatment options and success rates for helping patients at any stage of the disease.
March 1, 2016 - today announced it has treated the first RESCUE trial patient in the United States enrolled in an FDA-approved gene therapy vision research study. This represents a significant new chapter in the potentially wider use of gene therapy for treating, curing or even reversing certain cases of vision loss. The hope for the 50 year old patient, who has a vision-threatening genetic disease called Leber’s Hereditary Optic Neuropathy (LHON) is that his eye-injection will correct the defective gene that is causing his severe vision loss and either stops the progression of the disease or reverses the damage and improves his sight.
Millions of people in the United States have undetected vision problems and eye conditions. We need your help encouraging people in your community to schedule eye exams. Through a comprehensive dilated eye exam, eye care professionals can detect common vision problems and eye diseases, many of which have no early warning signs.
Wills Eye Hospital has been recognized as one of the two
best hospitals nationwide in Ophthalmology by U.S. News & World Report in its 2016-2017 annual survey.
These are medications that many patients with eye conditions use every day, and it can be frustrating to run out of your drops early or have trouble getting your drops in. So we're going to try and give you some tips to help out with that.
Diabetes is expected to impact 50% of all Americans by the year 2050. What's even more troubling is that according to the American Diabetes Association, 86 million Americans are pre-diabetic -- with 77 million of them not even realizing they are at risk for having the disease. In many cases, patients first learn of having the disease after experiencing acute vision symptoms. Here's how Wills Eye is making major strides in tackling this epidemic.
A first-of-its-kind, potentially groundbreaking new option for treating a form of eye cancer is now in its first phase-1 clinical research trial at Wills Eye Hospital in Philadelphia.
Julia A. Haller, MD, Ophthalmologist-in-Chief of Wills Eye Hospital in Philadelphia talks about Healthy Vision Month and what you may not know about taking care of your eyes.
Monday August 21, 2017. Viewing this event can damage your eyes. Here is important information from Wills Eye Hospital, The American Academy of Ophthalmology, NASA and the American Astronomical Society.
Medical experts from the renowned Wills Eye Hospital in Philadelphia are available for interviews about the vision risks associated with the Eclipse, what eye conditions aren’t safe for eclipse viewing, how the damage can occur and how to safely watch the event.
Wills Eye Retina Fellow, Christopher Aderman, MD, is this year’s recipient of the prestigious Ronald G. Michels Fellowship Foundation award. The honor is being announced at the Annual Meeting of the American Academy of Ophthalmology this weekend in New Orleans.
Ophthalmologists from Wills Eye Hospital are teaming up with Philadelphia Fire Department Officials throughout the big holiday week this week to send the all- important public safety message to always leave fireworks to the professionals and not risk devastating injuries to your eyes, hands or the rest of your body.
Wills Eye Hospital has been given Food and Drug Administration (FDA) approval to begin an early feasibility study (EFS) to implant the RETINA IMPLANT Alpha AMS sub-retinal device in patients blind due to Retinitis Pigmentosa (RP).
I am a captain for a major airline and was on a four day trip in July, 2017. On day three, I was walking through the Denver airport going to my next flight when I noticed a curtain starting to come across the vision in my right eye.
The Wills Eye at Jefferson Residency Program has been voted the #1 medical education training program in ophthalmology in the nation according to Doximity.com. The Wills Eye Hospital faculty serve as the department of Ophthalmology at Thomas Jefferson University Hospital and the Sidney Kimmel Medical College at Thomas Jefferson University.
My name is Dr. Reza Razeghinejad from Wills Eye Glaucoma service. One of the question that usually get from Glaucoma patient is that if caffeine is good for glaucoma or not.
Wills Eye Hospital Physicians are once again named to Philadelphia Magazine’s Annual “Top Docs” list from a vote by their peers throughout the region. The full medical list includes more than 2600 physicians and spans 66 different subspecialties. The names are chosen from Castle Connolly’s online physician poll.
Julia A. Haller, MD, the ophthalmologist-in-chief of Wills Eye Hospital, is the recipient of this year’s Physician of the Year Award from The Philadelphia Inquirer.
Wills Eye Hospital is taking top honors again this year for the best residency training program in the USA for ophthalmologists. Doximity, which coordinates the vote, is the largest online physician network and is a navigator for medical students considering residency programs.
Wills Eye Hospital is pleased to announce the opening of the new J. Arch McNamara, MD Ophthalmic Education Center, a transformational destination for global learning and innovation based at Wills Eye Hospital. The Center is named for Dr. J. Arch McNamara, a beloved surgeon on the Wills Retina Service, clinician investigator, educator, and leader in the field, who passed away in 2010.
Wills Eye Hospital today announced its Ophthalmologist-in-Chief, Julia A. Haller, MD, has been elected to the National Academy of Medicine (NAM), considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service.
Awards were presented to Philadelphia Mayor Jim Kenney; Thomas Jefferson University President and Jefferson Health CEO, Stephen Klasko, MD, MBA; Benefactor Steven H. Korman and Wills Eye Alumnus and Surgeon-Scientist, Jay Duker, MD
A first-of-its-kind conference taking a broad approach to discussing how Optical Coherence Tomography (OCT) can be utilized in valuable ways from the perspective of each section of the eye will take place at Wills Eye Hospital, Saturday, January 25, 2020.
Wills Eye Hospital is pleased to announce Jose S. Pulido, MD, MS, MBA, MPH, a world-renowned retina and ocular oncology clinician-scientist, has been named the Larry A. Donoso Endowed Chair and Director of the Henry and Corrine Bower Memorial Laboratories for Translational Medicine, the Vickie and Jack Farber Vision Research Center at Wills Eye.
The 2020 Power List is out and six Wills Eye Hospital faculty Ophthalmologists are named among the most influential figures in the field based on their scope of knowledge and professional achievements. Director of the Wills Eye Ocular Oncology Service Carol L. Shields, MD was listed the #1 most influential ophthalmologist in the world and the only female physician to make the top 10. Leaders were selected based on nominations from readers of the U.K.-based news magazine, The Ophthalmologist that publishes the list. The final top 100 list was released in March 2020.
Wills Eye Ophthalmologists are once again prominently listed among Philadelphia Magazine’s Annual Top Doctors list in its May 2020 issue. On the list, Wills Eye Physicians from every subspecialty within the field of ophthalmology are named.
New data published in the Journal Science Translational Medicine shows encouraging results in a worldwide clinical trial for patients diagnosed with the neuro-degenerative blinding eye disease; Leber Hereditary Optic Neuropathy (LHON.)
Ten remarkable women who are Wills Eye Hospital faculty physicians and Wills Eye alumnae have been named to the Inaugural all-women Power List, published by The Ophthalmologist.
Wills Eye Hospital attendings, faculty, and trainees this week presented 25 papers and posters at the Association for Research in Vision and Ophthalmology (ARVO) all virtual conference.
Fifty-six Wills Eye ophthalmologists have been named on the new 2021 Philadelphia Magazine Top Doctors list. Physicians are nominated by their peers and the magazine publishes the names after a nationwide online physician poll by Castle Connolly.